Heberprot-P-associated metabolic control in patients with diabetic foot ulcers
Diabetes mellitus is a unmet medical need of significant social and economical impact. Diabetic foot is a chronic and avoidable complication, and still the source of non-traumatic amputations, with metabolic imbalance, macroand micro-angiopathy, and ulceration or trauma contributing to its developme...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elfos Scientiae
|
Series: | Biotecnología Aplicada |
Subjects: | |
Online Access: | http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522010000200003&lng=en&tlng=en |
id |
doaj-2dd8bb2f6c3f4534a8ddbe178e404c32 |
---|---|
record_format |
Article |
spelling |
doaj-2dd8bb2f6c3f4534a8ddbe178e404c322020-11-25T02:52:01ZengElfos ScientiaeBiotecnología Aplicada1027-285227298100S1027-28522010000200003Heberprot-P-associated metabolic control in patients with diabetic foot ulcersEduardo Álvarez0Orestes L Faget1Neraldo Orlandi2Omaida F Torres3Instituto Nacional de Endocrinología (INEN)Instituto Nacional de Endocrinología (INEN)Instituto Nacional de Endocrinología (INEN)Hospital Universitario Julio Trigo LópezDiabetes mellitus is a unmet medical need of significant social and economical impact. Diabetic foot is a chronic and avoidable complication, and still the source of non-traumatic amputations, with metabolic imbalance, macroand micro-angiopathy, and ulceration or trauma contributing to its development. The introduction of Heberprot-P to treat diabetic foot ulcers has been a tremendous advance to reduce the amputation index and disability among patients. However, it is essential to guarantee an optimal and personalized glycemic control for achieving even more favorable results. This can be attained by implementing an intensive therapeutic strategy with multiple doses of insulin since the very first diagnose of the lesion. Due to the relevance of this topic for medical practice, here is reviewed how to establish such a therapy, and the goals for glycemic control to achieve a better quality of life when attending diabetic foot ulcer patients.http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522010000200003&lng=en&tlng=endiabetes mellituspie diabéticocontrol glucémicocontrol metabólicoheberprot-p |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eduardo Álvarez Orestes L Faget Neraldo Orlandi Omaida F Torres |
spellingShingle |
Eduardo Álvarez Orestes L Faget Neraldo Orlandi Omaida F Torres Heberprot-P-associated metabolic control in patients with diabetic foot ulcers Biotecnología Aplicada diabetes mellitus pie diabético control glucémico control metabólico heberprot-p |
author_facet |
Eduardo Álvarez Orestes L Faget Neraldo Orlandi Omaida F Torres |
author_sort |
Eduardo Álvarez |
title |
Heberprot-P-associated metabolic control in patients with diabetic foot ulcers |
title_short |
Heberprot-P-associated metabolic control in patients with diabetic foot ulcers |
title_full |
Heberprot-P-associated metabolic control in patients with diabetic foot ulcers |
title_fullStr |
Heberprot-P-associated metabolic control in patients with diabetic foot ulcers |
title_full_unstemmed |
Heberprot-P-associated metabolic control in patients with diabetic foot ulcers |
title_sort |
heberprot-p-associated metabolic control in patients with diabetic foot ulcers |
publisher |
Elfos Scientiae |
series |
Biotecnología Aplicada |
issn |
1027-2852 |
description |
Diabetes mellitus is a unmet medical need of significant social and economical impact. Diabetic foot is a chronic and avoidable complication, and still the source of non-traumatic amputations, with metabolic imbalance, macroand micro-angiopathy, and ulceration or trauma contributing to its development. The introduction of Heberprot-P to treat diabetic foot ulcers has been a tremendous advance to reduce the amputation index and disability among patients. However, it is essential to guarantee an optimal and personalized glycemic control for achieving even more favorable results. This can be attained by implementing an intensive therapeutic strategy with multiple doses of insulin since the very first diagnose of the lesion. Due to the relevance of this topic for medical practice, here is reviewed how to establish such a therapy, and the goals for glycemic control to achieve a better quality of life when attending diabetic foot ulcer patients. |
topic |
diabetes mellitus pie diabético control glucémico control metabólico heberprot-p |
url |
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522010000200003&lng=en&tlng=en |
work_keys_str_mv |
AT eduardoalvarez heberprotpassociatedmetaboliccontrolinpatientswithdiabeticfootulcers AT oresteslfaget heberprotpassociatedmetaboliccontrolinpatientswithdiabeticfootulcers AT neraldoorlandi heberprotpassociatedmetaboliccontrolinpatientswithdiabeticfootulcers AT omaidaftorres heberprotpassociatedmetaboliccontrolinpatientswithdiabeticfootulcers |
_version_ |
1724731972965629952 |